In another phase 3 trial, SURPASS-3, published by Rosenstock et al
Unlike sildenafil or tadalafil, which improve sexual performance by increasing nitric oxide and enhancing blood flow, PT-141 initiates arousal via brain centers and the neural pathways, making it a distinct alternative for those dealing with psychogenic, neurogenic, or hormonal dysfunctions
One-month use is too brief to separate medication benefits from placebo response, calorie restriction alone, or initial water-weight loss
A small gain can happen because: Appetite signals are adjusting Daily carbs and water levels shift naturally Routines change slightly without you realising The time to check in with your clinician is when the trend keeps climbing steadily over a few weeks
Research Data Data above is summarised from preclinical and in-vitro literature and is provided for research orientation only
Study Overview The analysis included over 460,000 U.S